Leitner T, Korber B, Daniels M, Calef C, Foley B: HIV-1 subtype and circulating recombinant form (CRF) reference sequences, 2005. HIV sequence compendium 2005, 2005:41–48. 52. Carr JK, Foley BT, Leitner T, Salminen M, Korber B, McCutchan F: Reference sequences representing the principle genetic diversity of HIV-1 in the Pandemic. In Human retroviruses and AIDS 1998. Volume III. Edited by: Korber B, Kuiken CL, Foley B, Hahn B, McCutchan F, Mellors JW, Sodroski J. Los Alamos, NM: Theoretical Biology
and Biophysics Group, Los Alamos National Laboratory; 1998:10–19. 53. Robertson DL, CP673451 chemical structure Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Kalish ML, Salminen M, Sharp PM, Wolinsky S, Korber B: HIV-1 nomenclature proposal. In Human Retroviruses and AIDS 1999. Edited by: Kuiken CL, Foley B, Hahn B, Korber B, McCutchan F, Marx PA, Mellors JW, Mullins JI, Sodroski
J, Wolinsky S. Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory; 1999:492–505. 54. Kuiken C, selleck chemicals Korber B, Shafer RW: HIV sequence databases. AIDS reviews 2003,5(1):52–61.PubMed 55. Davies MN, Guan P, Blythe MJ, Salomon J, Toseland CP, Hattotuwagama C, Walshe V, Doytchinova IA, Flower DR: Using databases and data mining in vaccinology. Expert Opinion on Drug Discovery 2007,2(1):19–35.CrossRef 56. Frahm N, Linde C, Brander C: Identification of HIV-derived, HLA class I restricted CTL epitopes: insights into TCR repertoire, CTL escape and viral fitness. HIV molecular immunology 2006, 2007:3–28. 57. Korber B, Gnanakaran S: The implications of patterns in HIV diversity for neutralizing antibody AZD2281 molecular weight induction and susceptibility. Current Opinion in HIV and AIDS 2009,4(5):408–417.PubMedCrossRef 58. Zolla-Pazner S, Cardozo T: Structure-function relationships of HIV-1 envelope sequence-variable Selleckchem MG-132 regions refocus vaccine design. Nature Reviews Immunology 2010,10(7):527–535.PubMedCrossRef 59. Sette A, Peters B: Immune epitope mapping in the post-genomic era: lessons for vaccine development. Curr Opin Immunol 2007,19(1):106–110.PubMedCrossRef
60. Malherbe L: T-cell epitope mapping. Annals of Allergy, Asthma and Immunology 2009,103(1):76–79.CrossRef 61. Gorny MK, Gianakakos V, Sharpe S, Zolla-Pazner S: Generation of human monoclonal antibodies to human immunodeficiency virus. Proceedings of the National Academy of Sciences 1989,86(5):1624–1628.CrossRef 62. Grimison B, Laurence J: Immunodominant epitope regions of HIV-1 reverse transcriptase: correlations with HIV-1 serum IgG inhibitory to polymerase activity and with disease progression. JAIDS J Acquired Immune Defic Syndromes 1995,9(1):58–68. 63. Kanduc D, Serpico R, Lucchese A, Shoenfeld Y: Correlating low-similarity peptide sequences and HIV B-cell epitopes. Autoimmun Rev 2008,7(4):291–296.PubMedCrossRef 64.
No related posts.